AI assistant
Chemours Co — Director's Dealing 2021
Jan 6, 2021
31561_dirs_2021-01-05_0ba178ee-fea2-42eb-bac7-91e3a4120257.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Chemours Co (CC)
CIK: 0001627223
Period of Report: 2020-12-31
Reporting Person: BELL BRADLEY J (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-12-31 | Stock Units | $ | A | 605.0827 | Acquired | Common Stock (605.0827) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 49470.4825 | Direct |
| Common Stock | 20400 | Indirect |
Footnotes
F1: Includes directly owned shares, stock units and dividend equivalent units.
F2: Units are credited under the Chemours compensation plan for directors and convert one-for-one to Chemours common stock.
F3: Payable in installments upon separation from service.
F4: This total has been adjusted to reflect the correct number of derivative securities beneficially owned due to a clerical error that overreported the total derivative securities in previous filings. With respect to the Form 4 filing on 04-30-2020, Table II, Box 9 should have been 6475.5096. With respect to the Form 4 filing on 07-02-2020, Table II, Box 9 should have been 7558.0357. With respect to the Form 4 filing on 10-02-2020, Table II, Box 9 should have been 8364.1052.